News

A new paper in the Proceedings of the National Academy of Sciences (PNAS) reports how a cutting-edge artificial intelligence technique called deep learning can automatically identify, count and describe animals in their natural habitats.

Stanford scientists and their collaborators have discovered a molecule that initiates the final, crucial step in a type of cell death.

Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.

Depression in type-1 diabetes patients is associated with higher levels of the inflammatory protein galectin-3. These findings suggest that galectin-3 levels may be a new target for treating depression associated with type-1 diabetes, which could lead to better patient care.

A protein in the brain that binds to alcohol could be the key to curing alcoholism

The human glutamine transporter ASCT2 is upregulated in several forms of cancer. It is also the docking platform for a wide range of pathogenic retroviruses. A team of University of Groningen scientists have used cryo-electron microscopy to elucidate the structure of the protein, which may generate leads for drug development.

The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as cetuximab. Often, the problem is that while treatments initially work, cancer evolves to resist treatment. Colorado study suggests new combination treatment against relapsed head and neck cancer.

Researchers report the deepest scientific understanding yet of this once-mysterious enzyme, whose catalytic core -- where most of its activity occurs -- can now be seen in near atomic resolution. Telomerase is especially active in cancer cells, which enables cancer to grow and spread.

New research indicates that opioid misuse and the use of cannabis and other drugs may compromise the effectiveness of treatments for alcohol use disorder.

Researchers have synthesized the first artificial human prion